10,108
Total Claims
$569K
Drug Cost
684
Beneficiaries
$832
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-41%
Cost per patient vs peers
$832 vs $1,411 avg
-51%
Brand preference vs peers
5.2% vs 10.6% avg
Brand vs Generic
95% generic
Brand: 523 claims · $322K
Generic: 9,547 claims · $246K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 64 | $79K |
| Empagliflozin | 92 | $78K |
| Dapagliflozin Propanediol | 61 | $53K |
| Atorvastatin Calcium | 985 | $18K |
| Valsartan/Hydrochlorothiazide | 222 | $17K |
| Ezetimibe | 284 | $17K |
| Rosuvastatin Calcium | 437 | $14K |
| Raloxifene Hcl | 166 | $14K |
| Valsartan | 286 | $10K |
| Apixaban | 13 | $9,832 |
| Rivaroxaban | 19 | $9,759 |
| Losartan Potassium | 443 | $8,021 |
| Amlodipine Besylate | 678 | $7,894 |
| Olmesartan Medoxomil | 194 | $7,810 |
| Metoprolol Succinate | 331 | $7,673 |
Prescribing Profile
86
Unique Drugs
$230K
Patient Profile
74
Avg Age
45%
Female
1.46
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data